Preparing for Mpox Resurgence: Surveillance Lessons From Outbreaks in Toronto, Canada
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad533 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Herveen Sachdeva und 14 weiteren Autor:innen. Beteiligte Einrichtung: Toronto Public Health. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Vaccines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
With many global jurisdictions, Toronto, Canada, experienced an mpox outbreak in spring/summer 2022. Cases declined following implementation of a large vaccination campaign. A surge in early 2023 led to speculation that asymptomatic and/or undetected local transmission was occurring in the city.
Methods
Mpox cases and positive laboratory results are reported to Toronto Public Health. Epidemic curves and descriptive risk factor summaries for the 2022 and 2023 outbreaks were generated. First- and second-dose vaccination was monitored. Mpox virus wastewater surveillance and whole genome sequencing were conducted to generate hypotheses about the source of the 2023 resurgence.
Results
An overall 515 cases were reported in spring/summer 2022 and 17 in the 2022–2023 resurgence. Wastewater data correlated with the timing of cases. Whole genome sequencing showed that 2022–2023 cases were distinct from 2022 cases and closer to sequences from another country, suggesting a new importation as a source. At the start of the resurgence, approximately 16% of first-dose vaccine recipients had completed their second dose.
Conclusions
This investigation demonstrates the importance of ongoing surveillance and preparedness for mpox outbreaks. Undetected local transmission was not a likely source of the 2022–2023 resurgence. Ongoing preexposure vaccine promotion remains important to mitigate disease burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Toronto Public Health.
- Dalla Lana School of Public Health, University of Toronto.
- Public Health Ontario, Toronto.
- Axe Maladies infectieuses et immunitaires, Centre de recherche du CHU de Québec-Université Laval.
- Wastewater Surveillance Unit, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba.
- MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto.
Zitieren
APA
Sachdeva, H., Shahin, R., Ota, S., Isabel, S., Mangat, C. S., Stuart, R., Padhi, S., Chris, A., Mishra, S., Tan, D. H. S., Braukmann, T. W., Eshaghi, A., Mejia, E. M., Hizon, N. A., & Finkelstein, M. (2024). Preparing for Mpox Resurgence: Surveillance Lessons From Outbreaks in Toronto, Canada. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad533
Vancouver
Sachdeva H, Shahin R, Ota S, Isabel S, Mangat CS, Stuart R, et al. Preparing for Mpox Resurgence: Surveillance Lessons From Outbreaks in Toronto, Canada. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad533
BibTeX
@article{Sachdeva2024,
author = {Sachdeva, Herveen and Shahin, Rita and Ota, Sylvia and Isabel, Sandra and Mangat, Chand S and Stuart, Rebecca and Padhi, Shovita and Chris, Allison and Mishra, Sharmistha and Tan, Darrell H S and Braukmann, Tom W and Eshaghi, AliReza and Mejia, Edgard M and Hizon, Nikho A and Finkelstein, Michael},
title = {Preparing for Mpox Resurgence: Surveillance Lessons From Outbreaks in Toronto, Canada},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad533}
}
EUVIMED